INTRODUCTION
Patients undergoing surgical resection for a malignant bone tumor (BT) or soft tissue tumor (STT), e.g., sarcomas, are at high risk for infectious complications [1] . A recent meta-analysis of 48 studies involving 4838 patients who underwent surgery for malignant BTs of the lower extremities showed a postoperative infection rate of 10% [2] . Similar postoperative infection rates of around 10% were reported in STT patients [3] . A longer duration of surgery, invalidating surgery, impaired systemic or local immunosuppressive state due to chemotherapy or adjuvant radiation, poor general performance status and implanted material left at the operative site may decrease host defenses, leading to infection [4, 5] . Postsurgical infections can lead to reoperation with frequent need for prosthesis removal [6] in combination with antibiotic treatment, decreased function of the extremity and increased pain resulting in incremental healthcare costs [3, 7, 8] .
In the absence of renewed surgical intervention, antibiotic therapy for postsurgical infections shows success rates lower than 10% [1] . One of the reasons for this low success rate is the lack of data concerning the microbiological spectrum of infections following surgery for BTs and STTs.
First, isolation and identification of all causing bacteria are time consuming and not always successful [6] . anesthesiologists, medical microbiologists, infectious disease physicians and pharmacists.
All procedures followed were in accordance with the ethical standards.
Inclusion Criteria
Inclusion criteria were (1) histologically confirmed diagnosis of a malignant primary or secondary BT or a malignant STT, (2) surgical treatment for the tumor (tumor resection whether or not followed by reconstruction), 
Data Collection
The following data were collected from the medical records: (1) Antibiotic therapy given for postoperative surgical site infections was subdivided in (1) monotherapy for each bacterial isolate, (2) combination therapy for all isolated bacteria, (3) the antibiotic spectrum not covering all infectious bacteria, (4) probabilistic antibiotic therapy with negative microbiological cultures or (5) no antibiotic therapy.
Statistical Analysis
We performed a descriptive analysis of clinical and bacteriological data. The primary endpoint of this study was the difference in causative 
RESULTS

Patient Characteristics
Seventy-two consecutive patients who developed a postsurgical infection after resection of a BT (n = 42) or STT (n = 30) were included ( Fig. 1) . The study population is detailed in Table 1 patients, of whom 6 (20%) had a bacteremia with the same pathogen as found at the surgical site. = 18) , chondrosarcomas (n = 5), Ewing tumors (n = 2), chordomas (n = 3), giant cell tumors (n = 2), adamantinomas (n = 2) and undifferentiated BTs (n = 1). Secondary BTs (n = 9) were all metastatic adenocarcinoma. STTs (n = 30) included: synovialosarcomas (n = 2), (myxo)fibrosarcomas (n = 7), leiomyosarcomas (n = 4), liposarcomas (n = 7), rhabdomyosarcomas (n = 1) or undifferentiated STTs (n =
weeks; both = treated with antibiotics at least once for 6 weeks and at least once for 2 weeks e Early \1 month, late [1 month after last surgery for tumor 
Microbiological Features
Microbiological findings associated with postsurgical infections after resection of BTs and STTs are presented in Table 2 and Fig. 2 . Forty-four patients (62%) had a polymicrobial infections. Polymicrobial infection occurred more frequently in STTs than in BTs (93% vs. Staphylococci as a group were significantly more predominant in BTs than in STTs (76% vs. 52%; P = 0.03). S. aureus was present in 38% of BTs and 28% of STTs (P = 0.36) and coagulase-negative staphylococci (CNS) in 50%
of BTs and 28% of STTs (P = 0.06). Other gram-positive bacteria were significantly more frequent in STTs than in BTs (86% vs. 29%;
P\0.01), among which enterococci (52% vs. 19%; P\0.01) and streptococci (28% vs. 10%; P = 0.06) were predominant. Gram-negative bacteria were also significantly more frequent in STTs than in BTs (55% vs. 26%; P = 0.01), among which non-ESBL Enterobacteriaceae (24% vs. 52%; P = 0.02) and Pseudomonas aeruginosa (7% vs. 7%; P = 1.00) were most frequent.
We compared the microbial spectrum between prosthesis-associated infections (including patients' allografts and osteosynthesis material) and non-prosthesisassociated infections. We found that gram-negative bacteria occurred more frequently in postoperative infections without prosthesis material, 54% vs. 29% (P = 0.04).
Enterococci were more frequent in non-prosthesis-associated infections, 67% vs. 11% (P\0.01). Furthermore, the number of cultured bacteria was less in prosthesis-associated infections, with a mean 4.19 ± 2.56 bacteria in non-prosthesis infections and 2.96 ± 1.83 in prosthesis-associated infections (P = 0.05). We also subdivided BT and STT patients and compared their microbiological spectrum according to tumor treatment, e.g., resection and/or prosthesis in combination with additional chemo-or radiotherapy. In non-prosthesis-associated infections with or without additional chemo-or radiotherapy in BT patients, we found more frequent gram-negative bacteria (67% vs. 19%; P = 0.03), Enterococci (67% vs. 11%, P\0.01),
Enterobacteriaceae (67% vs. 17%; P = 0.02) and anaerobes (33% vs. 0%; P = 0.02). For STT patients no significant differences were found in the microbiological spectrum when comparing tumor treatment groups.
When comparing cellulitis and osteomyelitis infection irrespective of underlying malignancy, no significant differences were seen in the distribution of gram positives and gram negatives. However, anaerobes were more frequently isolated from cellulitis (30%) than from osteomyelitis (5.4%; P = 0.03).
Localization did not significantly affect the scope of causative pathogens, except for Proprionibacterium acnes, which was more frequent in the upper limbs compared to the vertebrae, pelvis and lower limbs (P = 0.02).
For BTs and STTs together, we found gram negatives in 82% of early acute infections, in 7% of late acute infections and in 11% of chronic infections (P\0.01).
Treatments for Infection
Surgery was followed by antibiotic treatment for almost all patients (99%). Thirty-six patients (50%) had one surgical intervention and 36 (50%) had more than one. The median duration of antibiotic treatment STTs: high risk of post-resection hematoma leading to colonization with microbiota anaerobic bacteria [9] , radiotherapy prior to surgery causing tissue hypo-oxygenation [10] and resection of tumors located near the pelvis that can lead to breaches in the digestive tract [11] . Few microbiological data on STTs are available in the literature. Only the study of Morii et al. [6] reported seven cases of STT patients, four of them presenting with postoperative infection due to S. aureus (50% MRSA), two with gram-negative bacteria (n = 2) and one with polymicrobial infection. In our study, gram-positive bacteria were predominant in both BT (88%) and STT infections (86%).
Second, we found that gram-negative bacteria, e.g., Enterobacteriaceae, were significantly more frequently isolated in STT patients than in BT patients (55% vs. 26%).
Differences in patient characteristics such as surgical treatment, presence or absence of prostheses, and other potential risk factors such as age, sex comorbidities [12] and radiotherapy could explain differences in the distribution of microbial spectra between BTs and STTs (and between osteomyelitis and cellulitis).
Our microbiological data concerning BTs (n = 42) are congruent with previous studies.
Gram-positive bacteria were isolated in 88% of the BT patients in our study, as compared to 63% in the study by Angelini et al. [13] .
Furthermore, in our study 71% of infections in BTs were polymicrobial, as compared to 26% [1] to 38% [10] of BTs and 74% of sacral BTs [14] reported by others. In prosthesis-associated nontumoral bone infections, monomicrobial infections-with a majority of staphylococci [2] -predominate, whereas in postsurgical BT infections the microbiological spectrum is often polymicrobial (38%) with gram-positive and -negative bacteria [13] . Staphylococci were predominant in BTs (76% in our study, similar to 85% in other reports [1, 6, 8, 15] ), with S. aureus in 38% and CNS in 82% in our study. Therefore, our study strengthens the need for efficient anti-staphylococcal therapy-always covering CNS-as empirical antibiotic treatment for infections after surgery for BTs.
Gram-negative bacteria grew in only 26% of BT patients in our study, mostly in pelvic tumors, chordomas and early acute infections occurring \1 month after oncologic surgery compared to 37% in the former literature [11] .
The dichotomy in our microbiological findings was clearer when comparing BTs and 
